Optimer Pharmaceuticals (OPTR)

Create an Alert
14.33 -0.11  -0.76%   NASDAQ Jun 19, 8:00PM BATS Real time Currency in USD

Optimer Pharmaceuticals Price / Sales Ratio TTM:

6.674 for June 19, 2013
View Full Chart

Optimer Pharmaceuticals Price / Sales Ratio TTM Chart

    Optimer Pharmaceuticals Historical Price / Sales Ratio TTM Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 32   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    June 19, 2013 6.674
    June 18, 2013 6.725
    June 17, 2013 6.720
    June 14, 2013 6.776
    June 13, 2013 6.818
    June 12, 2013 6.697
    June 11, 2013 6.851
    June 10, 2013 6.977
    June 7, 2013 6.930
    June 6, 2013 6.800
    June 5, 2013 6.730
    June 4, 2013 6.949
    June 3, 2013 6.949
    May 31, 2013 6.930
    May 30, 2013 6.902
    May 29, 2013 6.860
    May 28, 2013 6.884
    May 24, 2013 6.744
    May 23, 2013 6.832
    May 22, 2013 6.697
    May 21, 2013 6.720
    May 20, 2013 6.846
    May 17, 2013 6.972
    May 16, 2013 7.037
    May 15, 2013 7.536
       
    May 14, 2013 6.637
    May 13, 2013 6.828
    May 10, 2013 5.966
    May 9, 2013 6.949
    May 8, 2013 6.888
    May 7, 2013 7.046
    May 6, 2013 7.000
    May 3, 2013 7.033
    May 2, 2013 7.112
    May 1, 2013 6.981
    April 30, 2013 7.191
    April 29, 2013 6.912
    April 26, 2013 6.916
    April 25, 2013 6.921
    April 24, 2013 6.809
    April 23, 2013 6.888
    April 22, 2013 6.879
    April 19, 2013 6.981
    April 18, 2013 6.921
    April 17, 2013 6.884
    April 16, 2013 6.867
    April 15, 2013 6.795
    April 12, 2013 6.842
    April 11, 2013 6.907
    April 10, 2013 6.884

    About Price to Sales Ratio

    The price to sales ratio (PS ratio) is calculated by dividing stock price by the revenue per share. It is most useful for comparing companies within a sector or industry because "normal" values for this ratio vary from industry to industry. In general, low price to sales ratios are more appealing because they suggest that a company is undervalued.

    An example illustrating why PS ratios should not be compared across industries: On June 21, 2010, Starbucks had a PS ratio of 1.12 while Yahoo! had a PS ratio of 2.56. In other words, Yahoo! shareholders were paying $2.56 for $1 of sales while Starbucks shareholders would only pay $1.12 for $1 of sales. However, at that same moment, the two companies' price to earnings ratios were virtually identical (Starbucks: 28.09 and Yahoo!: 27.78). Hence, shareholders were paying nearly the same amount for $1.00 in earnings. The PS ratios, though, are less comparable since Yahoo!'s profit margins are much higher than that of Starbucks.

    For more information on evaluating valuation multiples similar to this, please see our original white paper research : Making Sense Of Valuation Multiples.
    Learn More

    Get data for

    OPTR Price / Sales Ratio TTM Benchmarks

    Companies
    ViroPharma 4.917
    Incyte 8.201
    Cempra

    OPTR Price / Sales Ratio TTM Rankings

    Overall 67th percentile
    5414 of 16782
    Sector 66th percentile
    476 of 1410 in Healthcare
    Industry 81st percentile
    86 of 454 in Biotechnology

    OPTR Price / Sales Ratio TTM Range, Past 5 Years

    Minimum 2.897 Nov 15 2012
    Maximum 689.80 Jun 26 2009
    Average 199.59

    Access watchlists and custom data alerts.
    Start your free account.

    Registering enables you to view unlimited pages per month.

    required
    required
    required
    required
    Get Started Now

    Already registered? Sign in here.

    document.write('');